SPOP inhibits HBV transcription and replication by ubiquitination and degradation of HNF1α
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.29254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Yubo Pi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Biology for Infectious Diseases, Department of Infectious Diseases, Ministry of Education, The Second Affiliated Hospital…. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: 111 Project, Science and Technology Research Program of Chongqing Municipal Education Commission, Chongqing Medical Scientific Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau).
Abstract (Originalsprache)
Hepatitis B virus (HBV) infection remains a significant public health burden worldwide. The persistence of covalently closed circular DNA (cccDNA) within the nucleus of infected hepatocytes is responsible for the failure of antiviral treatments. The ubiquitin proteasome system (UPS) has emerged as a promising antiviral target, as it can regulate HBV replication by promoting critical protein degradation in steps of viral life cycle. Speckle‐type POZ protein (SPOP) is a critical adaptor for Cul3‐RBX1 E3 ubiquitin ligase complex, but the effect of SPOP on HBV replication is less known. Here, we identified SPOP as a novel host antiviral factor against HBV infection. SPOP overexpression significantly inhibited the transcriptional activity of HBV cccDNA without affecting cccDNA level in HBV‐infected HepG2‐NTCP and primary human hepatocyte cells. Mechanism studies showed that SPOP interacted with hepatocyte nuclear factor 1α (HNF1α), and induced HNF1α degradation through host UPS pathway. Moreover, the antiviral role of SPOP was also confirmed in vivo. Together, our findings reveal that SPOP is a novel host factor which inhibits HBV transcription and replication by ubiquitination and degradation of HNF1α, providing a potential therapeutic strategy for the treatment of HBV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Molecular Biology for Infectious Diseases, Department of Infectious Diseases, Ministry of Education, The Second Affiliated Hospital of Chongqing Medical University, Institute for Viral Hepatitis, Chong…
- Chongqing Big Data Research Institute of Peking University, Chongqing, China.
- Key Laboratory of Laboratory Medical Diagnostics, Department of Laboratory Medicine, Ministry of Education, Chongqing Medical University, Chongqing, China.
ORCID-Profile: Kai Wang, Yanmeng Chen
Förderung
- 111 Project
- Science and Technology Research Program of Chongqing Municipal Education Commission
- Chongqing Medical Scientific Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau)
- CQMU Program for Youth Innovation in Future Medicine
- Kuanren talents program of the second affiliated hospital of Chongqing Medical University
- Innovative and Entrepreneurial Team of Chongqing Talents Plan
- National Natural Science Foundation of China
- Natural Science Foundation Project of Chongqing
Zitieren
APA
Pi, Y., Li, Y., Yan, Q., Luo, H., Zhou, P., Chang, W., Gong, D., Hu, Y., Wang, K., Tang, N., Huang, A., & Chen, Y. (2023). SPOP inhibits HBV transcription and replication by ubiquitination and degradation of HNF1α. Journal of Medical Virology. https://doi.org/10.1002/jmv.29254
Vancouver
Pi Y, Li Y, Yan Q, Luo H, Zhou P, Chang W, et al. SPOP inhibits HBV transcription and replication by ubiquitination and degradation of HNF1α. Journal of Medical Virology. 2023. doi:10.1002/jmv.29254
BibTeX
@article{Pi2023,
author = {Pi, Yubo and Li, Yang and Yan, Qi and Luo, Huimin and Zhou, Peng and Chang, Wenyi and Gong, Deao and Hu, Yuan and Wang, Kai and Tang, Ni and Huang, Ailong and Chen, Yanmeng},
title = {SPOP inhibits HBV transcription and replication by ubiquitination and degradation of HNF1α},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.29254}
}
EUVIMED